TY - JOUR
T1 - Verbal analgesia is as good as oral tramadol prior to intrauterine device (IUD) insertion, among nulliparous women
T2 - A randomized controlled trial
AU - Daykan, Yair
AU - Battino, Shlomo
AU - Arbib, Nissim
AU - Tamir Yaniv, Rina
AU - Schonman, Ron
AU - Klein, Zvi
AU - Pomeranz, Jonathan
AU - Pomeranz, Meir
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2021/3
Y1 - 2021/3
N2 - Objective: To compare two pain management strategies: oral tramadol or a verbal analgesia technique during insertion of an intrauterine device (IUD) among nulliparous women. Study design: In this randomized, controlled trial, 54 nulliparous women undergoing insertion of a levonorgestrel-releasing intrauterine device (IUD), from December 2015 to December 2018 were randomized to receive oral tramadol for analgesia or verbal analgesia prior to IUD insertion. Demographic data, clinical symptoms, visual analogue scale (VAS) and complications were reviewed from patient records. Results: There was no difference between the two groups regarding gravidity, age, smoking or body mass index. No significant differences were detected between the groups regarding the procedure, including ease of insertion (p = .415), number of insertion attempts (p = .514) and complications during the insertion (p = .150). Mean pain level by VAS was 4.5 ± 1.6 (range 2−8) for the tramadol group and 4.8 ± 2.4 (0−10) for the verbal analgesia group (p = .610). There was no spontaneous ejection of the IUD in either group, and no endometritis or discomfort that resulted in IUD removal. Conclusion: There was no benefit in using oral tramadol for analgesia prior to IUD insertion among nulliparous women. Verbal analgesia can be a suitable technique for this process and clinicians should become more familiar with its use.
AB - Objective: To compare two pain management strategies: oral tramadol or a verbal analgesia technique during insertion of an intrauterine device (IUD) among nulliparous women. Study design: In this randomized, controlled trial, 54 nulliparous women undergoing insertion of a levonorgestrel-releasing intrauterine device (IUD), from December 2015 to December 2018 were randomized to receive oral tramadol for analgesia or verbal analgesia prior to IUD insertion. Demographic data, clinical symptoms, visual analogue scale (VAS) and complications were reviewed from patient records. Results: There was no difference between the two groups regarding gravidity, age, smoking or body mass index. No significant differences were detected between the groups regarding the procedure, including ease of insertion (p = .415), number of insertion attempts (p = .514) and complications during the insertion (p = .150). Mean pain level by VAS was 4.5 ± 1.6 (range 2−8) for the tramadol group and 4.8 ± 2.4 (0−10) for the verbal analgesia group (p = .610). There was no spontaneous ejection of the IUD in either group, and no endometritis or discomfort that resulted in IUD removal. Conclusion: There was no benefit in using oral tramadol for analgesia prior to IUD insertion among nulliparous women. Verbal analgesia can be a suitable technique for this process and clinicians should become more familiar with its use.
KW - Analgesia
KW - Intrauterine device
KW - Nulliparous
KW - Pain
KW - Verbal analgesia
UR - http://www.scopus.com/inward/record.url?scp=85096192395&partnerID=8YFLogxK
U2 - 10.1016/j.ejogrb.2020.09.019
DO - 10.1016/j.ejogrb.2020.09.019
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33187752
AN - SCOPUS:85096192395
SN - 0301-2115
VL - 258
SP - 443
EP - 446
JO - European Journal of Obstetrics and Gynecology and Reproductive Biology
JF - European Journal of Obstetrics and Gynecology and Reproductive Biology
ER -